150 related articles for article (PubMed ID: 34708646)
1. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High
Suzuki H; Kaizuka Y; Tatsuta M; Tanaka H; Washiya N; Shirakami Y; Ooe K; Toyoshima A; Watabe T; Teramoto T; Sasaki I; Watanabe S; Ishioka NS; Hatazawa J; Uehara T; Arano Y
J Med Chem; 2021 Nov; 64(21):15846-15857. PubMed ID: 34708646
[TBL] [Abstract][Full Text] [Related]
2. Effects of
Tago T; Toyohara J; Fujimaki R; Tatsuta M; Song R; Hirano K; Iwai K; Tanaka H
Nucl Med Biol; 2021; 94-95():38-45. PubMed ID: 33493787
[TBL] [Abstract][Full Text] [Related]
3. [Chemical Design of Radiohalogenated Agents Using Neopentyl Structure].
Uehara T
Yakugaku Zasshi; 2024; 144(3):285-290. PubMed ID: 38432938
[TBL] [Abstract][Full Text] [Related]
4. In vivo stable
Suzuki H; Kannaka K; Hirayama M; Yamashita T; Kaizuka Y; Kobayashi R; Yasuda T; Takahashi K; Uehara T
EJNMMI Radiopharm Chem; 2024 Jun; 9(1):48. PubMed ID: 38884866
[TBL] [Abstract][Full Text] [Related]
5. Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives.
Wilbur DS; Hamlin DK; Chyan MK; Kegley BB; Quinn J; Vessella RL
Bioconjug Chem; 2004; 15(3):601-16. PubMed ID: 15149189
[TBL] [Abstract][Full Text] [Related]
6. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
[TBL] [Abstract][Full Text] [Related]
7. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
8. Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals.
Pruszyński M; Łyczko M; Bilewicz A; Zalutsky MR
Nucl Med Biol; 2015 May; 42(5):439-445. PubMed ID: 25687450
[TBL] [Abstract][Full Text] [Related]
9. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
[TBL] [Abstract][Full Text] [Related]
10. Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics.
Kaizuka Y; Suzuki H; Watabe T; Ooe K; Toyoshima A; Takahashi K; Sawada K; Iimori T; Masuda Y; Uno T; Kannaka K; Uehara T
EJNMMI Radiopharm Chem; 2024 Feb; 9(1):17. PubMed ID: 38407647
[TBL] [Abstract][Full Text] [Related]
11. 1-(
Sasaki I; Tada M; Liu Z; Tatsuta M; Okura T; Aoki M; Takahashi K; Ishioka NS; Watanabe S; Tanaka H
Org Biomol Chem; 2023 Sep; 21(36):7467-7472. PubMed ID: 37670575
[TBL] [Abstract][Full Text] [Related]
12. Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).
Bartholomä MD; Gottumukkala V; Zhang S; Baker A; Dunning P; Fahey FH; Treves ST; Packard AB
J Med Chem; 2012 Dec; 55(24):11004-12. PubMed ID: 23210516
[TBL] [Abstract][Full Text] [Related]
13. Design of silicon-based misonidazole analogues and (18)F-radiolabelling.
Bohn P; Deyine A; Azzouz R; Bailly L; Fiol-Petit C; Bischoff L; Fruit C; Marsais F; Vera P
Nucl Med Biol; 2009 Nov; 36(8):895-905. PubMed ID: 19875046
[TBL] [Abstract][Full Text] [Related]
14. Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents.
Nurhidayah W; Setyawati LU; Daruwati I; Gazzali AM; Subroto T; Muchtaridi M
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432107
[TBL] [Abstract][Full Text] [Related]
15. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
[TBL] [Abstract][Full Text] [Related]
16. Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.
Teze D; Sergentu DC; Kalichuk V; Barbet J; Deniaud D; Galland N; Maurice R; Montavon G
Sci Rep; 2017 May; 7(1):2579. PubMed ID: 28566709
[No Abstract] [Full Text] [Related]
17.
Maingueneau C; Berdal M; Eychenne R; Gaschet J; Chérel M; Gestin JF; Guérard F
Chemistry; 2022 Feb; 28(11):e202104169. PubMed ID: 34965315
[TBL] [Abstract][Full Text] [Related]
18. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18.
Boss SD; Betzel T; Müller C; Fischer CR; Haller S; Reber J; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2016 Jan; 27(1):74-86. PubMed ID: 26634288
[TBL] [Abstract][Full Text] [Related]
19. A Novel PET Probe "[
Shimizu Y; Zhao S; Yasui H; Nishijima KI; Matsumoto H; Shiga T; Tamaki N; Ogawa M; Kuge Y
Mol Imaging Biol; 2019 Feb; 21(1):122-129. PubMed ID: 29845425
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
